The US pharmaceutical excipient market is estimated to grow at a CAGR of 7.9% during the forecast period. The presence of a well-established pharmaceutical industry in the country considerably contributes to the growth of the market. A rise in the generic drugs industry has been observed significantly. The generic drug manufacturers are dedicated to increasing the Abbreviated New Drug Application (ANDA) filings. They are adopting the business model that relies on highly outsourcing and supports for optimizing efficiencies. Moreover, the recent COVID-19 outbreak in the country and across the globe has increased the demand for drugs for the prevention and treatment of the virus. This, in turn, has significantly increased the demand for pharmaceutical excipient and hence drives the market growth.

The US pharmaceutical excipient market is segmented on the basis of product and formulations. Based on the product, the market is segmented into solubilizers & surfactants/emulsifiers, polyols, carbohydrates, and specialty excipients. Solubilizers & Surfactants/Emulsifiers covered in the report include triglycerides, esters, and others. in addition, polyols include mannitol, sorbitol, and others. Carbohydrates including sucrose, dextrose, starch, and others are estimated to hold a prominent share in the market. Based on formulations, the market is segmented into oral formulations, topical formulations, parenteral formulations, and other formulations. Oral formulations held a remarkable share in the market.

Moreover, the US pharmaceutical excipients market report covers the analysis of various players operating in the market. Some of the global players operating in the US market include Merck KGaA, Colorcon Inc., Innophos Holdings, Inc., Lubrizol Corp., Archer Daniels Midland Co., and others. Owing to increasing competition in the market, the players in the market adopting various strategies such as merger and acquisition and partnership and collaboration that tend to fuel market growth in the near future. 

For instance, In December 2019, Colorcon Inc. announced the new development of On-Dose Authentication capability for tracking and tracing functionality for supply chain security. The Opadry fully formulated film coating system decreases the risk of counterfeit drugs in the supply chain. In the same month, the company completed the expansion and renovation of the North American production facility in Pennsylvania. Due to expansion, the supply chain robustness of solid oral dosage products increases in North America and Latin America.

Research Methodology

The market study of the US pharmaceutical excipients market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research has been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report is intended for pharmaceutical excipients manufacturers, suppliers, raw material suppliers, traders, third-party distributors, healthcare industry, pharmaceutical and biopharmaceutical manufacturers, government organizations, regulatory authorities, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, products & services offered by the companies, and future market opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. US Pharmaceutical Excipients Market Research and Analysis by Product
2. US Pharmaceutical Excipients Market Research and Analysis by Formulations

The Report Covers

• Comprehensive research methodology of the US Pharmaceutical Excipients Market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the US Pharmaceutical Excipients Market.
• Insights about market determinants which are stimulating the US Pharmaceutical Excipients Market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.